Breakthrough in Preventing Breast Cancer

25/04/2006

Today, CBS' Dr. Sean Kenniff Has More About New Research, On An Old Drug

(CBS News) You May Have Heard News This Week About A Big Breakthrough In Preventing Breast Cancer.

Today, CBS' Dr. Sean Kenniff Has More About New Research, On An Old Drug.

When It Comes To Preventing Breast Cancer, Tamoxifen Has Long Been The Gold Standard.

The Drug Is Highly Effective At Reducing Cancer Growth.

But Results From A Large New Study Show.... A Drug Now Used To Treat Osteoporosis Called Raloxifene May Be A Better Choice For Some Women.

Dr. Judy Garber/Dana Farber Cancer Institute
"They Show That Raloxifene Is As Good As Tamoxifen At Reducing The Risk Of Breast Cancer."

The National Cancer Institute Trial Involved Almost 20-Thousand Postmenopausal Women At A High Risk Of Breast Cancer.

Researchers Found Raloxifene And Tamoxifen Were About The Same At Preventing The Disease.

However, Patients Tolerated Raloxifene Much Better.

In The Group Of Women On The Treatment There Were 36 Percent Fewer Uterine Cancers And 29 Percent Fewer Blood Clots.

Dr. Sean Kenniff/CBS News
“Tamoxifen And Raloxifene Work The Same Way By Blocking Hormones That Can Fuel Cancer Growth. But With The Fewer Side Effects Researchers Expect Raloxifene To Eventualy Become The New Standard.”

Dr. Judy Garber/Dana Farber Cancer Institute
"For Postmenopausal Women Raloxifene Is Likely To Replace Tamoxifen As The Drug Of Choice For Reducing The Risk Of Breast Cancer."

That Could Include Study Participant Suzanne Blanchard, Who's Daughter And Sister Both Fell Victim To The Disease.

Suzanne Blanchard/Study Participant
"The Road To Prevention Is Much Better Than Curing Cancer After People Have It."

For Younger Women Tamoxifen Is Still The Standard For Prevention. But Now Post-Menopausal Patients Have A Choice.

(© MMVI, CBS Broadcasting Inc. All Rights Reserved)



Back to previous page